Immunotherapy against programmed death-1/programmed death ligand 1 in hepatocellular carcinoma: Importance of molecular variations, cellular heterogeneity, and cancer stem cells

Hepatocellular carcinoma (HCC) is a heterogeneous malignancy related to diverse etiological factors. Different oncogenic mechanisms and genetic variations lead to multiple HCC molecular classifications. Recently, an immune-based strategy using immune checkpoint inhibitors (ICIs) was presented in HCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukowati, Caecilia H C, El-Khobar, Korri Elvanita, Tiribelli, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316870/
https://www.ncbi.nlm.nih.gov/pubmed/34367478
http://dx.doi.org/10.4252/wjsc.v13.i7.795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316870/
https://www.ncbi.nlm.nih.gov/pubmed/34367478
http://dx.doi.org/10.4252/wjsc.v13.i7.795

Ejemplares similares